PharmaBoardroom

Serge Kemps – CEO, Nipro Medical Europe

Serge Kemps, CEO of Nipro Medical Europe, sits down with PharmaBoardroom to shed light on Nipro’s unique corporate culture based on the Japanese…

Christoph Stoller – President & Adrian van den Hoven…

In the wake of the publication of Medicines for Europe’s Lessons Learned from COVID-19 policy paper, Christoph Stoller & Adrian van den Hoven…

Qing Liu – VP, Clinical & Regulatory Affairs, Arctic…

Dr Qing Liu, Arctic Vision’s VP for Clinical & Regulatory Affairs, shares her key priorities and the potential for top-line ophthalmological…

Yi (York) Chen – VP, Operations & Commercial Planning,…

Dr Yi (York) Chen, VP for operations and commercial planning at Arctic Vision shares his priorities, his wide experience of ophthalmology product…

Launching Zolgensma® in Belgium: Lessons Learned

In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy Zolgensma® for the ultra-rare…

Algeria Pharma News Roundup July 2020

Below we present recent news from Algeria’s pharmaceutical industry, including the creation of a dedicated Ministry to boost the sector, changes to…

Can We Afford to Pay for Future Cures?

Pharmaceutical innovation is racing ahead of the US health system's ability to adjust payment models, but innovative concepts are finally emerging. We…

Jin LI – Chairman & CEO, HitGen, China

Dr Jin Li explains Chinese firm HitGen’s unique drug discovery technology platform, how its ability to screen billions of molecules has the…

Teresa Rodó – EVP, Head of Global Healthcare Operations,…

Teresa Rodó gives an overview of her role overseeing the development, manufacturing, supply, and quality of all of Merck’s biotech and…

3 Ways the UK’s Pharma Sector is Driving Innovation

Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical industry’s rapid response to…

China Pharma News Roundup July 14th 2020

A roundup of the latest from Chinese pharma and biotech, including Boehringer Ingelheim’s new Shanghai R&D hub, new HKEX IPO successes for…

New Billion Dollar Pharma Action Fund to Counter ‘Slow…

June 9th 2020 saw the launch of a new action fund on antimicrobial resistance (AMR), with 23 leading biopharmaceutical companies committing to almost…

Tagged with P